News Center

Home page

Peak Report

News reports

Pharmaceutical Sales Company Deploys Work in 2017

Release time:

2020-08-14

Pharmaceutical Sales Company Deploys 2017 Work

News 1# September 15 , 24 , Peak Pharmaceutical Sales Company successively held terminal and agent annual summary meetings to review 2016 and deploy 2017 Work. At the terminal sales summary meeting held on January 15

, the managers of each office made a report on the work of

2016 , summarizing the gains and losses of the work, analyzing the existing problems and exchanging the work plan for the new year. Xu Junxiong, executive deputy general manager of Pharmaceutical Sales Company, summarized the overall situation of terminal sales from the aspects of sales performance, specific work and existing problems. Focusing on the work focus of "increasing incentives, emphasizing academics and strengthening promotion", he made arrangements for the work of 2017 in terms of incentive mechanism, team building, bidding and bargaining, marketing innovation and academic promotion, and read out the 2017 terminal sales target decomposition plan and assessment criteria. Jin Xuecai, deputy general manager of Pharmaceutical Company and general manager of Pharmaceutical Sales Company, commented on the advantages and disadvantages of terminal sales 2016 at the meeting. According to the current development trend of the pharmaceutical industry, he asked all offices to seize the opportunity of medical insurance adjustment and strengthen hospital development. Strengthen communication and visit to achieve sales volume; Increase academic promotion and actively respond to trend changes; salesmen should strengthen their own training and learning, strengthen the internal management of the office; innovate the sales model and do a good job in terminal sales. At the

meeting, the level of salesmen was also evaluated according to their work performance, the collectives and individuals who won the annual sales competition award were commended, and the annual sales responsibility system was signed with each office. At the agency sales meeting held on January 24 , each regional manager summarized and reported the work in the first half of the year from the aspects of product sales, new customer development, existing problems, new year's work and goal realization. Regional managers and managers evaluate the reporter from five aspects, such as enterprise loyalty, sales performance over the years, annual sales performance, and market development ability, and ask questions about the main points of the report.

The meeting discussed and approved a new regional manager incentive and appraisal plan, announced the decision to merge several regions with smaller sales, and conducted a regional manager competition. Participants are ranked by the evaluation scores obtained in the previous report. The top ten regional managers give priority to regional bargaining. After three rounds of bidding, the competition results are finally determined. At the agent sales meeting, Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company, analyzed the current situation of the pharmaceutical industry from many aspects and pointed out the challenges and opportunities. He said that the incentive policy for regional managers will be adjusted, and he hopes that all regions will have a deep understanding of the new policy and resolutely implement it. Jiang Xiaomeng, chairman of

group company and chairman of pharmaceutical company, attended the agency sales meeting and delivered a speech. He commented on the agency sales work, pointed out that some personnel have problems such as lack of self-confidence, low morale, few methods, and serious inert thinking. Pharmaceutical sales companies are required to organize various trainings in a targeted manner, and sales personnel should also strengthen learning., Improve their own sales skills, think carefully according to the life cycle and sales strategy of the company's key products, and solve the problems in sales. (Ni Yingzhen Xu Xianzhong)

More information

The company fully deploys 2018 work

On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals

2020

07-30

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise

On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

The company was rated as an advanced unit of the city's focus on talent and love talent.

News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)

2020

07-31

< 1...38 39 40...61 > 跳转到页